Fidia operates across different therapeutic areas, focusing on commonly occurring pathologies with serious social and economic impact, age-related disorders and other health-related conditions, as life expectancy lengthens and chronic, disabling diseases increase as a result.

The company’s overall objective is establishing its leadership, through developing and marketing innovative pharmaceutical products, medical devices and healthcare ‘lifestyle’ products, primarily based on hyaluronic acid (HA) and its derivatives, thereby providing patients and healthcare professionals with a variety of treatment options, in strategic areas such as joint care and musculoskeletal disorders.

Farmaceutici S.p.A.

Find out our Corporate Website:

Go to the website

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Russia product portfolio focalizes primarily on joint healthcare.

Fidia Pharma Russia is focused on providing consumers with innovative products that offer quality, safety and performance.